Fig. 6From: A combined risk model for the multi-encompassing identification of heterogeneities of prognoses, biological pathway variations and immune states for sepsis patientsModel evaluation on 3 sub-models, Combined-risk model and traditional indictors (PCT and IL8) in external validation cohort. The ROC indicated that the AUC of Molecule-risk model, Pathway-risk model, Immunity-risk model, Combined-risk model, IL8 and PCT were 0.810, 0.818, 0.621, 0.873, 0.585 and 0.565Back to article page